Drugs / Autologous immune enhancement therapy (AIET)
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT05520372 | Jan 2016 → Dec 2021 | — | Vinmec Research Institute of Stem Cell and Gene Technology | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Autologous immune enhancement therapy (AIET) | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05520372 ↗ |
| Known as | AIET | “Autologous immune enhancement therapy (AIET) for cancer patients” NCT05520372 ↗ |
| Modality | Cell therapy | “Autologous NK cell and CD8 T cell therapy for cancer patients” NCT05520372 ↗ |